Durvalumab plus olaparib in previously untreated, platinum-ineligible patients with metastatic urothelial carcinoma: A multicenter, randomized, phase II trial (BAYOU) Journal Article

   

Authors:	Rosenberg, J. E.; Park, S. H.; Kozlov, V.; Dao, T. V.; Castellano, D.; Li, J. R.; Mukherjee, S. D.; Howells, K.; Dry, H.; Lanasa, M. C.; Stewart, R.; Bajorin, D. F.
Article Title:	Durvalumab plus olaparib in previously untreated, platinum-ineligible patients with metastatic urothelial carcinoma: A multicenter, randomized, phase II trial (BAYOU)
Journal Title:	Journal of Clinical Oncology
Volume:	41
Issue:	1
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2023-01-01
Start Page:	43
End Page:	53
Language:	English
DOI:	10.1200/jco.22.00205
PROVIDER:	EBSCOhost
PROVIDER:	cinahl
PMCID:	PMC9788981
PUBMED:	35737919
DOI/URL:	https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=160929614&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes:	MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Alexander Drilon -- Accession Number: 160929614 -- Entry Date: In Process -- Revision Date: 20221226 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl

https://synapse.mskcc.org/synapse/works/has_related_data_chk/203016